Ricci Gabriele
Chief Data & Tech. Officer
Ricci Gabriele has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Ricci Gabriele is listed as Chief Data & Tech. Officer at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Ricci Gabriele reported no open-market purchases and 1 open-market sale totaling $429K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$429K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ricci Gabriele made?
Ricci Gabriele has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Ricci Gabriele trade?
Ricci Gabriele has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Ricci Gabriele's most recent SEC Form 4 filing?
Ricci Gabriele's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Ricci Gabriele's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ricci Gabriele is listed as Chief Data & Tech. Officer.
What is Ricci Gabriele's total buy and sell value in the current window?
Inside the rolling retention window, Ricci Gabriele bought $0 and sold $429K based on SEC Form 4 filings.
What was Ricci Gabriele's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,088 TAK shares on 2026-08-10, worth $429K, per SEC Form 4 filings.